With Biologics Spread Catalent Buys NJ Cell Therapy Plant
Catalent, the high-flying CDMO, is buying a cell therapy unit on the East Coast, only days after spending $350 million to strengthen up biologics...
Cancer Risk Leads Pfizer Recall Blood Pressure Drug From US
Pfizer's recall saga has now reached the United States, after elevated concentrations of potential carcinogens forced the company to pull multiple products in Canada....
FDA Seeks To Know How Prescription Drug Risks Are Weighed
The FDA's Office of Prescription Medicine Promotion (OPDP) intends to know how patients and doctors consider the risks and benefits of a new prescription medicine...
FDA clears Insulet’s next-generation Omnipod 5 wearable insulin delivery pump
Insulet added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January.
Omnipod 5 provides easier glucose management,...
COVID Jab Partner SII Stalls Output Due To 200M Unused Doses
As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's warehouses.
As per Bloomberg, Serum...
Sanofi Begins Work On €400 Million Singapore Future Facility
Sanofi's "factory of the future" in Singapore could be operational by the middle of the decade. One of two so-called Evolutive Vaccine Facilities (EVFs)...
Industry Minister- Indian Pharma Should Focus On Generics
To become self-reliant, Union Commerce and Industry Minister of India, Piyush Goyal advised the domestic pharmaceutical sector to develop its generic medicine segment and provide greater...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...